Vera Therapeutics, Inc. VERA

Set alert

Price alert · VERA

All alert types
30.78 USD +0.53 +1.75%

As of Nov 3, 2:05 PM ET

Bid
30.77 × 1
Ask
30.83 × 1
29.90 Day range 31.19
23.05 52-week range 56.05
YTD
-39.22%
1 year
+18.66%
Open
30.26
Prev close
30.25
Mkt cap
2.22B
Vol
780.25K
Avg vol
2.14M
EPS
-5.87
P/E
0.00
Div yield
0.00%
More statistics
Low
29.90
High
31.19
Forward P/E
-7.12
Beta
1.19
Short ratio
5.52
Inst. own
117.99%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
32.00
200-d avg
36.96
1y target
74.20

3M chart

Chart tools
Interval

Events in this range
  • Aug 10, 2026Earnings: -1.52; estimate -1.58; surprise 3.8%
  • Aug 11, 2026Rating: Wedbush · Neutral → Neutral
  • Aug 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 17, 2026Rating: Wedbush · Neutral → Neutral
  • Sep 8, 2026Rating: JP Morgan · Overweight → Overweight
  • Oct 12, 2026Rating: Leerink Partners · — → Market Perform
Signals (18)
NameDateAgo
SMA: BullishNov 3, 20264 hours ago
SMA: BearishNov 2, 20261 day ago
SMA: BullishOct 28, 20266 days ago
MACD: Buy SignalOct 20, 20262 weeks ago
RSI: OversoldOct 13, 20263 weeks ago
MACD: Sell SignalSep 24, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
SMA: BullishSep 21, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BearishSep 16, 20261 month ago
MACD: Sell SignalSep 16, 20261 month ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago
RSI: OversoldAug 4, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 74.20 +141.1% upside
Target (low)
34.00
Target (mean)
74.20
Target (high)
100.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy12
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 14
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VERA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.61-1.80 – -1.39-1.26-27.6%3.74M0.0%9
Next quarter-1.54-2.18 – -1.21-1.39-10.9%17.44M0.0%9
Current year-6.25-7.23 – -5.77-4.66-34.2%24.83M0.0%10
Next year-4.25-6.72 – -2.23-6.25+32.0%233.76M+841.4%10

Upgrades and downgrades

The latest rating changes

VERA analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Leerink PartnersInitiated—Market Perform
Sep 8, 2026JP MorganMaintainedOverweightOverweight
Aug 17, 2026WedbushReiteratedNeutralNeutral
Aug 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2026WedbushMaintainedNeutralNeutral
Jul 8, 2026TD CowenMaintainedBuyBuy
Jul 8, 2026GuggenheimMaintainedBuyBuy
Jul 8, 2026WedbushMaintainedNeutralNeutral
Jul 8, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 7, 2026B of A SecuritiesMaintainedBuyBuy
May 15, 2026Evercore ISI GroupMaintainedOutperformOutperform
Mar 11, 2026Wolfe ResearchUpgradePeer PerformOutperform
Mar 2, 2026HC Wainwright & Co.MaintainedBuyBuy
Dec 19, 2025B of A SecuritiesMaintainedBuyBuy
Dec 19, 2025Goldman SachsMaintainedBuyBuy
Dec 19, 2025JP MorganMaintainedOverweightOverweight
Dec 11, 2025WedbushMaintainedNeutralNeutral
Dec 8, 2025Evercore ISI GroupMaintainedOutperformOutperform
Dec 5, 2025TD CowenMaintainedBuyBuy
Nov 10, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 7, 2025JP MorganMaintainedOverweightOverweight
Oct 16, 2025B of A SecuritiesInitiated—Buy
Aug 7, 2025JP MorganMaintainedOverweightOverweight
Aug 4, 2025Wolfe ResearchDowngradeOutperformPeer Perform
Jun 2, 2025ScotiabankMaintainedSector OutperformSector Outperform
Jun 2, 2025HC Wainwright & Co.MaintainedBuyBuy
May 12, 2025ScotiabankMaintainedSector OutperformSector Outperform
May 7, 2025WedbushMaintainedNeutralNeutral
May 7, 2025Cantor FitzgeraldMaintainedOverweightOverweight
Mar 4, 2025JP MorganMaintainedOverweightOverweight